Should the thyroid AUS/FLUS category be further stratified by malignancy risk?

E-ISSN： 1934-6638|122|7|481-483

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.122, Iss.7, 2014-07, pp. : 481-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implementing noninvasive follicular thyroid neoplasm with papillary‐like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN

DIAGNOSTIC CYTOPATHOLOGY, Vol. 46, Iss. 2, 2018-02 ,pp. : 148-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malignancy in Solitary Thyroid Nodules: Evaluation of Risk Factors

Oncology Research and Treatment, Vol. 40, Iss. 6, 2017-05 ,pp. : 360-363

Karger

Access to resources Recommend Favorite

Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine‐needle aspiration cytology

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 2, 2015-02 ,pp. : 260-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative 131I dose over 37 GBq

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 1, 2015-07 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 439-444

John Wiley & Sons Inc

Access to resources Recommend Favorite